PHS
PFM Health Sciences’s Erasca ERAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
1,072,224
-2,417,335
| -69% | -$3.07M | 0.12% | 52 |
|
|
2025
Q1 | $4.78M | Sell |
3,489,559
-900,868
| -21% | -$1.23M | 0.35% | 41 |
|
|
2024
Q4 | $11M | Sell |
4,390,427
-486,484
| -10% | -$1.22M | 0.68% | 34 |
|
|
2024
Q3 | $13.3M | Buy |
4,876,911
+205,137
| +4% | +$560K | 0.75% | 33 |
|
|
2024
Q2 | $11M | Buy |
4,671,774
+2,136,672
| +84% | +$5.04M | 0.55% | 42 |
|
|
2024
Q1 | $5.22M | Sell |
2,535,102
-40,409
| -2% | -$83.2K | 0.25% | 63 |
|
|
2023
Q4 | $5.49M | Sell |
2,575,511
-1,355,122
| -34% | -$2.89M | 0.33% | 51 |
|
|
2023
Q3 | $7.74M | Sell |
3,930,633
-866,827
| -18% | -$1.71M | 0.36% | 57 |
|
|
2023
Q2 | $13.2M | Hold |
4,797,460
| – | – | 0.51% | 51 |
|
|
2023
Q1 | $14.4M | Hold |
4,797,460
| – | – | 0.64% | 51 |
|
|
2022
Q4 | $20.7M | Sell |
4,797,460
-2,467,521
| -34% | -$10.6M | 0.74% | 44 |
|
|
2022
Q3 | $56.7M | Buy |
7,264,981
+1,383,599
| +24% | +$10.8M | 2.05% | 13 |
|
|
2022
Q2 | $32.8M | Buy |
5,881,382
+1,089,976
| +23% | +$6.07M | 1.25% | 35 |
|
|
2022
Q1 | $41.2M | Sell |
4,791,406
-399,999
| -8% | -$3.44M | 1.54% | 27 |
|
|
2021
Q4 | $77M | Hold |
5,191,405
| – | – | 2.62% | 10 |
|
|
2021
Q3 | $98.2M | Buy |
+5,191,405
| New | +$98.2M | 2.89% | 7 |
|